Arcutis Biotherapeutics recently reported positive topline results from its INTEGUMENT-INFANT Phase 2 trial, showing that ZORYVE cream 0.05% improved disease severity and was well tolerated in 101 ...
As a child nutritionist and a mom of twins, I've noticed a troubling pattern in my practice: eczema cases in young Indian ...
During the cold winter months, many people notice their skin’s condition worsens. Dry air and indoor heating can exacerbate symptoms of eczema, or atopic dermatitis. This leads to dry, cracked ...
Dermatologists share the best body lotions for mature skin to help improve dryness, firmness and elasticity, with top picks ...
Topical pumecitinib 3% gel shows strong efficacy and good tolerability in mild-to-moderate atopic dermatitis. Explore the ...
INDICATIONS ZORYVE cream, 0.05%, is indicated for topical treatment of mild to moderate atopic dermatitis in pediatric patients 2 to 5 years of age. ZORYVE cream, 0.15%, is indicated for topical ...
A large pharmacovigilance analysis of FDA adverse event reports shows no significant lymphoma safety signal with topical calcineurin inhibitors for atopic dermatitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results